NCT01114594

Brief Summary

The aim of this pilot project is to assess the potential of urine micro-RNAs (miRNA) as biomarkers for characterizing patients with autosomal dominant polycystic kidney disease (ADPKD) compared with patients with other causes of chronic kidney disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

April 26, 2010

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 3, 2010

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
Last Updated

November 6, 2018

Status Verified

November 1, 2018

Enrollment Period

2 years

First QC Date

April 26, 2010

Last Update Submit

November 2, 2018

Conditions

Keywords

Chronic Kidney Disease (CKD)Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Outcome Measures

Primary Outcomes (1)

  • Identification of micro-RNA Biomarkers Associated with Autosomal Dominant Chronic Kidney Disease

    5 years

Study Arms (2)

PKD

Patients with Autosomal Dominant Polycystic Kidney Disease

non-PKD CKD

Patients with non-Polycystic Chronic Kidney Disease

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

20 outpatients, 20 patients control

You may qualify if:

  • Male or female subject, 18 years of age or older, with diagnosis of ADPKD or non-PKD-CKD
  • If female, not pregnant.
  • Willing and able to understand and sign informed consent

You may not qualify if:

  • Presenting with any signs or symptoms of an infectious disease
  • Bacterial infection determined by urine culture
  • Use of systemic steroids within a week prior to screening
  • History, physical, or laboratory findings suggestive of any other medical or psychological condition that would, in the opinion of the Principal Investigator, make the candidate ineligible for the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Rogosin Institute

New York, New York, 10021, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Plasma, serum, monocytes, urine

MeSH Terms

Conditions

Renal Insufficiency, ChronicPolycystic Kidney, Autosomal Dominant

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsPolycystic Kidney DiseasesKidney Diseases, CysticAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCiliopathiesGenetic Diseases, Inborn

Study Officials

  • Jon Blumenfeld, MD

    The Rogosin Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2010

First Posted

May 3, 2010

Study Start

April 1, 2010

Primary Completion

April 1, 2012

Study Completion

April 1, 2012

Last Updated

November 6, 2018

Record last verified: 2018-11

Locations